Imunon, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Imunon, Inc. (IMNN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 14.00 thousand shares for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2016-03-30
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2014-12-31 was -932.86K shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2014-03-31 was 1.18M shares, a 7733.81% increase year-over-year.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-12-31 was -174.90K shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-09-30 was -657.22K shares, a 4481.49% decline year-over-year.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 14.00K shares, a 34.40% decline from fiscal 2014.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 21.34K shares, a 65.78% increase from fiscal 2013.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 12.87K shares, a 77.30% decline from fiscal 2012.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 56.71K shares, a 279.76% increase from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 54 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 57 month |
|---|---|---|---|---|---|---|---|
| 2015-12-31 | 14.00K shares 10-K · filed 2016-03-30 | ||||||
| 2014-12-31 | -932.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 21.34K shares 10-K · filed 2016-03-30 | |||||
| 2014-09-30 | 954.20K shares 10-Q · filed 2014-11-10 | ||||||
| 2014-03-31 | 1.18M shares 10-Q · filed 2014-05-08 | 1.00M shares derived: sum of 2 quarters · filed 2016-03-30 | 342.94K shares derived: sum of 3 quarters · filed 2016-03-30 | 1.17M shares derived: sum of 4 quarters · filed 2016-03-30 | |||
| 2013-12-31 | -174.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -832.13K shares derived: sum of 2 quarters · filed 2016-03-30 | -2.13K shares derived: sum of 3 quarters · filed 2016-03-30 | 12.87K shares 10-K · filed 2016-03-30 | |||
| 2013-09-30 | -657.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 172.78K shares derived: sum of 2 quarters · filed 2013-11-12 | 187.78K shares 10-Q · filed 2013-11-12 | -378.76K shares derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-06-30 | 830.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 845.00K shares 10-Q · filed 2013-08-08 | 278.46K shares derived: sum of 3 quarters · filed 2015-03-12 | 293.46K shares derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-03-31 | 15.00K shares 10-Q · filed 2013-05-09 | -551.54K shares derived: sum of 2 quarters · filed 2015-03-12 | -536.54K shares derived: sum of 3 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -566.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -551.54K shares derived: sum of 2 quarters · filed 2015-03-12 | 56.71K shares 10-K · filed 2015-03-12 | 668.49K shares 10-K · filed 2013-03-18 | |||
| 2012-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 623.25K shares 10-Q · filed 2012-11-09 | 3.48M shares 10-Q · filed 2012-11-09 | ||||
| 2012-06-30 | 608.25K shares 10-Q · filed 2012-08-14 | 3.55M shares 10-Q · filed 2012-08-14 | |||||
| 2011-12-31 | 14.93K shares 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |